All articles by GlobalData Healthcare

Chronic hepatitis B therapeutics market to reach $3.2bn across 7MM in 2034

The CHB therapeutics market across the 7MM, comprising the US, 5EU, and Japan, is forecast to grow from $1.5bn in…
CKD-HPT, HP and HK market to reach $4bn across 7MM by 2034

The chronic kidney disease (CKD)-hyperparathyroidism (HPT), hyperphosphatemia (HP) and hyperkalemia (HK) market is poised to grow at a compound annual…
7MM autism spectrum disorder market to reach $2bn by 2034

The autism spectrum disorder (ASD) market across the seven major markets (7MM: France, Germany, Italy, Japan, Spain, the UK and…
Cell and gene therapy landscape in respiratory diseases and future outlook

One of the biggest challenges to the cell and gene therapy (CGT) landscape over the last couple of years has…
2025 dominates for GLP-1 trial activity

GLP-1 development has massively increased over the five years since 2020 and has become a major trend within diabetes and…

Rise of ultra-processed food is detriment to global health

Noncommunicable diseases (NCDs) such as cardiovascular diseases, obesity and type 2 diabetes are collectively responsible for around 74% of all…
Measles-free status of Canada revoked

On 10 November 2025, the revocation of Canada's measles elimination status was announced by the Pan American Health Organization (PAHO).…
Obstructive sleep apnea independently associated with cerebral microbleeds

Obstructive sleep apnea (OSA) is a condition in which airflow is blocked during sleep for longer than 10 seconds at…
AHA 2025: SHR-1918’s impact on hyperlipidaemia through angiopoietin-like 3 inhibition

On 10 October, at the American Heart Association (AHA) 2025 conference in New Orleans, Louisiana, US, during a late-breaking session…
Physical activity effects mortality risk in epilepsy

Exercise has traditionally been associated with better health outcomes. According to the World Health Organization, there are various physical and…